Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
Prostate enlargement is a common age-related condition affecting millions of men. Learn about its symptoms, risk factors, ...
These can all be symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. While BPH is common as ...
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
6don MSN
Nebraska Hematology Oncology becomes state’s only trial site for new prostate cancer treatment
The treatment, called Pasritamig, teaches the immune system's T cells to target and attack cancer cells in the prostate.
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
Irish Examiner on MSN
'Every effort must be made' to provide prostate cancer drug to public patients
Novartis manufacturers Pluvicto which benefits men with advanced prostate cancer, and oncologists have told the HSE that ...
The 68-year-old previously told how his diagnosis came as a 'real bolt from the blue' ...
Men might benefit if doctors quit referring to low-risk prostate cancer as cancer at all, a new study says. Referring to the ...
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...
Federal health officials are quietly moving to overhaul the fine print on testosterone replacement therapy, a shift that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results